Latest Headlines

  1. Merck Breaks Ground On New Biologics And ADC Manufacturing Facility In Delaware 4/29/2025

    Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware.

  2. Amgen Reveals $900 Million Plant Manufacturing Expansion In Ohio 4/28/2025

    Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number of jobs created to 750 and the total investment in Central Ohio to over $1.4 billion.

  3. PCI Pharma Services To Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea 4/24/2025

    PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea, Inc. (“Althea”), a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co., Inc. Scheduled for completion in May 2025, the acquisition provides PCI with its first-ever North American manufacturing location for prefilled syringes and cartridges – including isolator technology for these formats – as well as high potent manufacturing suitable for antibody-drug conjugates (ADCs).

  4. Alconox Announces Extended Shelf Life Of Critical Cleaning Detergents For Life Sciences 4/24/2025

    Alconox Inc. is pleased to announce that we have extended the shelf life of our critical cleaning detergents from 2 years (24 months) to 3.5 years (42 months). This significant improvement in shelf life is based on extensive stability testing, and our goal of continuous improvement. Thus ensuring the continued reliability and performance of our detergents throughout this extended period.

  5. Tanner Pharma Group Opens New Secondary Packaging And Distribution Facility In Charlotte, NC 4/24/2025

    Tanner Pharma Group has announced the opening of its new US operations facility in Charlotte, NC. This purpose-built, 22,000+ square foot facility represents a significant investment in enhancing the company’s secondary packaging, labeling, storage and distribution capabilities to meet the evolving needs of its pharmaceutical partners.

  6. Bayer Unveils New Packaging Lines At Myerstown PA Manufacturing Facility Following $44 Million Investment 4/22/2025

    Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer’s commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community.

  7. Novo Nordisk Announces Significant Investment To Expand Its Montes Claros Brazil Manufacturing Site 4/9/2025

    Novo Nordisk today announced an investment of R$6.4 billion (8 billion Danish kroner) to expand its production facility in Montes Claros, northern Minas Gerais, with the aim of increasing production capacity for injectable treatments for people with obesity, diabetes and other serious chronic diseases.

  8. INTERPHEX Announces Exhibitor Awards And Recap Of 2025 Conference 4/4/2025

    INTERPHEX 2025, the leading global trade event for pharmaceutical and biotechnology professionals, concluded with resounding success after three days (April 1-3, 2025) at the Javits Center. This year’s event brought together nearly 10,000 industry professionals representing all stages of the pharmaceutical product development lifecycle. With 550+ exhibitors, cutting-edge innovations, and countless opportunities for meaningful engagement, INTERPHEX 2025 proved to be a defining moment for the future of pharmaceutical and biotechnology advancements.

  9. AustinPx Launches KinetiSol™ Equipment Lease Program 4/1/2025

    AustinPx announced the introduction of the KinetiLease™ program, allowing pharmaceutical companies to lease the company’s KinetiSol™ research-scale equipment

  10. AustinPx Launches KinetiSol Equipment Lease Program 4/1/2025

    AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally delivered small molecule drugs, today announced the introduction of the KinetiLease program, allowing pharmaceutical companies to lease the company’s KinetiSol research-scale equipment.